Literature DB >> 33893944

Bone Tissue Metabolism in Dynamics of Experimental Knee Osteoarthrosis Induced by Dexamethasone and Talcum.

E V Gladkova1, Yu K Gladkova2, V Yu Ulyanov1.   

Abstract

We studied remodeling of the bone tissue in the dynamics of experimental dexamethasoneand talcum-induced knee osteoarthrosis. Disturbed osteoclastogenesis accompanied by a decrease in the production of fibroblast growth factor-23 and elevation of serum osteoprotegerin and osteocalcin were observed at the early stages of the disease. During progression of degenerative and dystrophic processes in the joint tissues, an increase in sclerostin concentrations, a decrease in osteocalcin content, and changes in the force and direction of correlations between osteoblast processes and osteoclastogenesis as well as hierarchic distribution of the dominating mechanism of subchondral remodeling were revealed.

Entities:  

Keywords:  bone remodeling marker; dexamethasone; experimental osteoarthrosis; talcum

Year:  2021        PMID: 33893944     DOI: 10.1007/s10517-021-05143-1

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  1 in total

1.  Etoricoxib decreases subchondral bone mass and attenuates biomechanical properties at the early stage of osteoarthritis in a mouse model.

Authors:  Bo Liu; Chenchen Ji; Yijie Shao; Ting Liang; Jiaheng He; Huaye Jiang; Guangdong Chen; Zongping Luo
Journal:  Biomed Pharmacother       Date:  2020-04-21       Impact factor: 6.529

  1 in total
  2 in total

1.  Role of Imbalance of Lipid Peroxidation and Articular Cartilage Remodeling in the Pathogenesis of Early Primary and Post-Traumatic Gonarthrosis in Rats.

Authors:  Е V Gladkova
Journal:  Bull Exp Biol Med       Date:  2022-02-17       Impact factor: 0.804

2.  Metabolism of Subchondral Bone Tissue in Posttraumatic Osteoarthrosis in Rats.

Authors:  R А Zubavlenko; S V Belova; V Yu Ulyanov
Journal:  Bull Exp Biol Med       Date:  2021-12-02       Impact factor: 0.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.